НовостиBenzingaUBS Initiates Coverage On Bioage Labs with Neutral Rating, Announces Price Target of $8 UBS Initiates Coverage On Bioage Labs with Neutral Rating, Announces Price Target of $8 Benzinga 2026.10.12 13:35 (GMT+0) Открыть на Benzinga Другие новости